SCHEMBL7243129

SCHEMBL7243129

CCCCOC(=O)N1CCN(c2ncccc2C(=O)O)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.53
CHIA Q9BZP6 1/20 0.46
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR3A P46098 1/20 0.46
HTR3D Q70Z44 1/20 0.46
HTR3C Q8WXA8 1/20 0.46
TRPA1 O75762 2/20 0.45
OPRD1 P41143 1/20 0.45
OPRK1 P41145 1/20 0.45
MEN1 O00255 1/20 0.44
TRPV1 Q8NER1 3/20 0.43
HRH1 P35367 2/20 0.43
HRH2 P25021 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MYC P01106 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
NOS2 P35228 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275286 0.81 SMN1; SMN2 (0.55) HRH1HRH2SMN1; SMN2MYCLMNA
SCHEMBL7235994 0.81 CAPN1 (0.51) CHIAOPRD1OPRK1
SCHEMBL7235995 0.81 CAPN1 (0.47) KMT2ACHIAOPRD1OPRK1MEN1
SCHEMBL7235600 0.79 ALDH1A1 (0.53) KMT2AMEN1ALDH1A1NPC1GAA
SCHEMBL3668350 0.79 LMNA (0.47) KMT2ATRPA1OPRD1OPRK1MEN1
SCHEMBL4554527 0.79 POLB (0.61) KMT2ATRPA1TRPV1MYCPOLB
SCHEMBL27470853 0.79 HRH4 (0.53) KMT2AOPRD1OPRK1MEN1POLB
SCHEMBL31635760 0.78 SMN1; SMN2 (0.49) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL3693484 0.78 SMN1; SMN2 (0.49) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL1459682 0.76 MAPT (0.57) KMT2AMEN1HRH1HRH2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562827-B1 For the treatment of diseases in which increased calpain activity occurs such as neurodegenerative diseases or neuronal damage are caused by ischemia, trauma or mass hemorrhages ABBOTT LABORATORIES 2003-05-13 US disclosed